Cargando…

Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials

Current therapies for acute kidney injury remain primarily supportive and have failed to reduce morbidity, mortality (>50%), and associated costs. This prompted our studies in which rats with bilateral ischemia/reperfusion-induced acute kidney injury were treated with bone marrow-derived, culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Westenfelder, Christof, Togel, Florian E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089688/
https://www.ncbi.nlm.nih.gov/pubmed/25018910
http://dx.doi.org/10.1038/kisup.2011.24